Blood Group Typing Market

Blood Group Typing Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS11088
Available Format:
Category : Biotechnology

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Products & Service

1.3.2. Market Segmentation by Technique

1.3.3. Market Segmentation by Test Type

1.3.4. Market Segmentation by End User

1.3.5. Market Segmentation by Geography

1.3.6. Analysis Period

1.3.7. Market Data Reporting Unit Value

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents By region By industry participants By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Product & Service Consumables Antisera reagents Anti-human globulin reagents Red blood cells reagents Blood bank saline Instruments Services

4.1.2. Overview by Technique PCR based and micro array techniques Assay based techniques Massively parallel sequencing techniques Others

4.1.3. Overview by Test Type Antibody screening HLA typing Cross-matching tests ABO blood tests Antigen typing

4.1.4. Overview by End User Hospitals Blood banks Clinical laboratories Others

4.2. Market Dynamics

4.2.1. Trends

4.2.2. Drivers Impact analysis of drivers on market forecast

4.2.3. Restraints Impact analysis of restraints on market forecast

4.2.4. Opportunities

4.3. Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Products & Service

5.1. Consumables

5.1.1. Antisera Reagents

5.1.2. Anti-Human Globulin Reagents

5.1.3. Red Blood Cells Reagent

5.1.4. Blood Bank Saline

5.2. Instruments

5.3. Services

Chapter 6. Market Size and Forecast by Technique

6.1. PCR-Based and Microarray Techniques

6.2. Assay-Based Techniques

6.3. Massively Parallel Sequencing Techniques

Chapter 7. Market Size and Forecast by Test Type

7.1. Antibody Screening

7.2. HLA Typing

7.3. Cross-Matching Tests

7.4. ABO Blood Tests

7.5. Antigen Typing

Chapter 8. Market Size and Forecast by End User

8.1. Hospitals

8.2. Blood Banks

8.3. Clinical Laboratories

Chapter 9. Market Size and Forecast by Geography

9.1. North America Blood Group Typing Market

9.1.1. By Product & Service

9.1.2. By Technique

9.1.3. By Test Type

9.1.4. By End User

9.1.5. By Country – The U.S. and Canada

9.2. Europe Blood Group Typing Market

9.2.1. By Product & Service

9.2.2. By Technique

9.2.3. By Test Type

9.2.4. By End User

9.2.5. By Country – The U.K., Germany, France, Italy, Spain and Rest of Europe

9.3. Asia-Pacific Blood Group Typing Market

9.3.1. By Product & Service

9.3.2. By Technique

9.3.3. By Test Type

9.3.4. By End User

9.3.5. By Country – Japan, China, India and Rest of Asia-Pacific

9.4. Latin America Blood Group Typing Market

9.4.1. By Product & Service

9.4.2. By Technique

9.4.3. By Test Type

9.4.4. By End User

9.4.5. By Country – Brazil and Rest of Latin America

9.5. Middle East & Africa Blood Group Typing Market

9.5.1. By Product & Service

9.5.2. By Technique

9.5.3. By Test Type

9.5.4. By End User

Chapter 10. Competitive Landscape

10.1. Competitive Analysis of Key Players

10.2. Global Strategic Developments

Chapter 11. Company Profiles

11.1. Bio-Rad Laboratories, Inc.

11.1.1. Business Overview

11.1.2. Product and Service Offerings

11.1.3. Key Financial Summary

11.1.4. Strategic Growth Plan

11.2. Immucor, Inc.

11.2.1. Business Overview

11.2.2. Product and Service Offerings

11.2.3. Key Financial Summary

11.2.4. Strategic Growth Plan

11.3. Quotient Limited

11.3.1. Business Overview

11.3.2. Product and Service Offerings

11.3.3. Key Financial Summary

11.3.4. Strategic Growth Plan

11.4. BAG Health Care GmbH

11.4.1. Business Overview

11.4.2. Product and Service Offerings

11.4.3. Key Financial Summary

11.4.4. Strategic Growth Plan

11.5. DAY medical SA

11.5.1. Business Overview

11.5.2. Product and Service Offerings

11.5.3. Key Financial Summary

11.5.4. Strategic Growth Plan

11.6. Grifols S.A.

11.6.1. Business Overview

11.6.2. Product and Service Offerings

11.6.3. Key Financial Summary

11.6.4. Strategic Growth Plan

11.7. Ortho Clinical Diagnostics, Inc.

11.7.1. Business Overview

11.7.2. Product and Service Offerings

11.7.3. Key Financial Summary

11.7.4. Strategic Growth Plan

11.8. Novacyt Group

11.8.1. Business Overview

11.8.2. Product and Service Offerings

11.8.3. Key Financial Summary

11.8.4. Strategic Growth Plan


11.9.1. Business Overview

11.9.2. Product and Service Offerings

11.9.3. Key Financial Summary

11.9.4. Strategic Growth Plan

11.10. AXO Science

11.10.1. Business Overview

11.10.2. Product and Service Offerings

11.10.3. Key Financial Summary

11.10.4. Strategic Growth Plan

11.11. Agena Bioscience, Inc.

11.11.1. Business Overview

11.11.2. Product and Service Offerings

11.11.3. Key Financial Summary

11.11.4. Strategic Growth Plan

*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.

Chapter 12. Appendix

12.1. Abbreviations

Place An Order

Single User License

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry